GlassScriptPhysician profile
Amy R Richter
NPI 1255315461
$1,979.67
in general payments reported to CMS, 2019-2025
17 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $167 · 2021: $451 · 2022: $120 · 2023: $225 · 2024: $254 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $578.61 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $187.46 | 2022-2025 | |
| Hologic Sales and Service, LLC | $156.82 | 2019 | |
| Amgen INC. | $143.15 | 2020-2024 | Evenity |
| Allergan, INC. | $137.76 | 2019-2020 | |
| Horizon Therapeutics Plc | $125.00 | 2021 | |
| Lupin INC. | $123.49 | 2019 | |
| Biogen, INC. | $114.88 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $94.52 | 2023-2025 | Veozah |
| Aspira Women'S Health INC | $65.43 | 2021 | |
| Daiichi Sankyo INC. | $63.12 | 2024 | Injectafer |
| Coopersurgical, INC. | $54.15 | 2021-2024 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $40.73 | 2020-2025 | |
| Idorsia Pharmaceuticals US INC | $35.00 | 2023 | Quviviq |
| Pfizer INC. | $28.00 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.07 | 2021 | |
| Therapeuticsmd, INC. | $15.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Richter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.